Related Experiment Video
Updated: Nov 7, 2025

Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
Organ Donation from Donors with Hepatitis B or C in South Korea: A 2013-2017 Nationwide Data Analysis
Hoonsung Park1, Eun-Sil Jung2, Myoung Hwa Lee3
1Department of Surgery, Korea University Medical Center, Korea University College of Medicine, Seoul, South Korea.
Insights
Organ donation from hepatitis B (HBV) and C (HCV) positive brain-dead donors is limited in South Korea. Recipient refusal and donor unsuitability are key barriers to successful transplantation.
Area of Science:
- Transplantation immunology
- Hepatology
- Public health
Background:
- Organ donation from hepatitis B (HBV) and hepatitis C (HCV) virus carriers is increasing.
- Data on organ donation from brain-dead donors with hepatitis in South Korea is limited.
- Analysis of organ donation from brain-dead donors with hepatitis is crucial for improving transplant rates.
Purpose of the Study:
- To analyze the current status of organ donation from brain-dead donors with hepatitis B or C in South Korea.
- To identify barriers to successful organ transplantation from hepatitis carriers.
- To propose strategies for increasing organ donation from HBV/HCV-positive donors.
Main Methods:
- Retrospective analysis of brain death reports and organ transplantation data in South Korea (2013-2017).
- Inclusion of 9210 potential brain deaths, with 333 identified as hepatitis carriers (HBV/HCV).
- Examination of 2460 completed transplantations, including 71 from hepatitis carriers.
Main Results:
- 60 and 11 transplantations were completed from HBV- and HCV-positive brain-dead donors, respectively.
- Primary reasons for transplantation failure included recipient refusal (n=90) and donor unsuitability (n=80).
- Kidney and liver donations were most common (71 and 31, respectively); HBV donors provided more organs on average than HCV donors.
Conclusions:
- Organ donation from brain-dead donors with hepatitis B or C leading to successful transplantation is infrequent in South Korea.
- Recipient refusal and donor unsuitability due to active viral conditions are major obstacles.
- Strategies to promote transplantation include recipient education, post-transplant infection management protocols, and enhanced medical staff training.
Abstract:
BACKGROUND The number of organ donations from hepatitis B virus (HBV) or hepatitis C virus (HCV)-positive donors is gradually increasing; however, the current status of organ donation from brain-dead donors with hepatitis in South Korea has not been analyzed. This study aimed to analyze this. MATERIAL AND METHODS In total, 9210 potential brain deaths were reported in South Korea from January 2013 to December 2017, of which 333 were hepatitis carriers (HBV, n=246; HCV, n=87). Based on the data from the Korean Network for Organ Sharing and Korea Organ Donation Agency, 2460 completion of transplantations from brain-dead donors have been performed, of which 71 were hepatitis carriers (HBV, n=60; HCV, n=11). RESULTS There were 60 and 11 transplantations from HBV- and HCV-positive brain-dead donors, respectively. The main reasons for organ transplantation failure were recipient's refusal (n=90), unsuitability as donors (n=80), non-brain death (n=45), and cardiac death (n=20). There were 71 and 31 kidney and liver donations, respectively; the average number of organs donated by HBV-positive donors was higher than that donated by HCV-positive donors. HBV-positive donors donated more hearts and livers than HCV-positive donors. CONCLUSIONS There are few organ donations from brain-dead donors with hepatitis B or C which led to transplantation completion in South Korea, and the main reasons for failure are recipient's refusal to receive organs from donors with hepatitis and unsuitability for donation due to active viral conditions. To promote organ transplantations from donors with hepatitis B and C virus, we could consider 3 strategies: 1) reducing recipient's refusal rates by educating recipients and their families on the outcomes of organ donation from hepatitis carriers, 2) establishing treatment protocols for infection management after organ transplantations from HBV/HCV brain-dead donors, and 3) increasing the relevant experience of medical staff.
More Related Videos
10:12Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...